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Abstract
Background: Granulysin produced by cytolytic T cells directly contributes to immune defense against tuberculosis (TB). We
investigated granulysin as a candidate immune marker for childhood and adolescent TB.
Methods: Peripheral blood mononuclear cells (PBMC) from children and adolescents (1–17 years) with active TB, latent TB
infection (LTBI), nontuberculous mycobacteria (NTM) infection and from uninfected controls were isolated and restimulated
in a 7-day restimulation assay. Intracellular staining was then performed to analyze antigen-specific induction of activation
markers and cytotoxic proteins, notably, granulysin in CD4
+ CD45RO
+ memory T cells.
Results: CD4
+ CD45RO
+ T cells co-expressing granulysin with specificity for Mycobacterium tuberculosis (Mtb) were present
in high frequency in TB-experienced children and adolescents. Proliferating memory T cells (CFSElowCD4
+CD45RO
+) were
identified as main source of granulysin and these cells expressed both central and effector memory phenotype. PBMC from
study participants after TB drug therapy revealed that granulysin-expressing CD4
+ T cells are long-lived, and express several
activation and cytotoxicity markers with a proportion of cells being interferon-gamma-positive. In addition, granulysin-
expressing T cell lines showed cytolytic activity against Mtb-infected target cells.
Conclusions: Our data suggest granulysin expression by CD4
+ memory T cells as candidate immune marker for TB infection,
notably, in childhood and adolescence.
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Introduction
Tuberculosis (TB) remains a leading cause of childhood
mortality worldwide with 300,000 cases per year estimated
globally and an unequal preponderance in developing countries
[1,2,3]. While intense research efforts have focused on TB in
adults, childhood TB has been largely neglected. Young children
are at a much higher risk of progressing to active disease than
adults. This is combined with higher mortality, with the highest
prevalence among children under 2 years of age and the lowest
between 5 and 10 years [4,5]. Children also have a higher risk of
extrapulmonary disease [6]. Due to its paucibacillary nature,
diagnosis of childhood TB remains challenging. Most children
with active TB are sputum smear negative. Less than 10–15% of
children with proven TB exhibit sputum smear positivity for acid-
fast bacteria [7]. The Mantoux tuberculin skin test (TST) in
children also results in poor specificity, especially in countries
where BCG vaccination is performed at birth. T cell-based
interferon-gamma (IFNc) release assays (IGRAs) offer some
advantages [8,9,10]. The most deterministic factors of possible
Mycobacterium tuberculosis (Mtb) infection in children, include
compatible clinical signs and symptoms, an X-ray indicative of
TB and likelihood of infection due to known contact [11].
Mtb primarily resides in phagosomes within macrophages and
hence its antigens are presented by class II major histocompat-
ibility complex (MHC) molecules to CD4
+ T cells. Studies in mice
lacking CD4
+ T cells have demonstrated the importance of this T
cell subset in the control of TB [12,13,14]. CD4
+ T cells activated
by Mtb antigens may also become cytotoxic T lymphocytes (CTL)
[15,16,17,18,19]. The critical role of CD4
+ T cells in control of
Mtb is further underlined by the high incidence of TB in HIV
+
individuals whose CD4
+ T cell compartment is affected [20].
CD4
+ CTL express granzymes, FAS ligand (Fas-L), perforin and
granulysin [21]. Granzymes and perforin directly kill target cells,
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expresses potent bactericidal activity and can directly attack Mtb
in combination with granzymes and perforin [22,23,24]. Granu-
lysin is expressed after 3–5 days following T cell activation [25]. It
is generally present in human CTL, but a homologous molecule
has not been described in mice [26]. We determined the
expression of the cytotoxic granule protein granulysin in Mtb-
specific CD4
+ T cells after 7 days of in vitro stimulation. Thus,
detection of granulysin-expressing CD4
+ memory T cells could
serve as basis for development of an immune marker for diagnosis
of childhood and adolescent TB.
Methods
Ethics statement
The study using samples from children [EA2/0128/4] was
approved by the Charite ´ Ethics Committee University Hospital
Berlin, Germany. T cells lines were generated from PBMC from
adult TST
+ donors and approved by the Charite ´ Ethics
Committee University Hospital Berlin, Germany [EA1/200/08].
Written informed consent was provided by all study participants or
their legal guardians. Study participant groups are listed in
Table 1.
Study participants
To investigate the role of cytolytic T cells in childhood/
adolescent TB, a total of 59 individuals (1–17 years; median age:
10 years) were recruited at the Department of Paediatric
Pneumology and Immunology of the Charite ´ University Hospital,
Berlin, Germany. Individuals were characterized and defined as
follows: Study participants with active TB had proven family
contact to infectious TB and/or bacteriology (staining and/or
culture and/or PCR), also positive TST and IGRA testing, as well
as typical chest X-ray findings. Individuals with latent TB infection
(LTBI) had proven family contact to patients with infectious TB
and were also positive for TST and IGRA testing, but showed
negative bacteriology and normal chest X-ray. Nontuberculous
mycobacteria (NTM)-diseased participants showed cervical
lymphadenitis, TST
+ and negative IGRA. Bacterial culture for
NTM after lymph node excision showed exclusive infection with
M. avium and histological proof of epitheloid cell granulomatosis.
In all cases, a TST was considered positive when induration was
.5 mm. QuantiferonH TB-Gold In-Tube was used as IGRA
according to manufacturer’s instructions. An IGRA result was
considered positive, when reaction to TB antigens minus the nil
tube control was $0.35 IU/ml. Individuals with bacteriologically
proven TB under antimycobacterial therapy were initially treated
with a combination of isoniazid (INH), rifampicin (RMP) and
pyrazinamide (PZA) [27]. For participants with advanced forms of
TB, ethambutol (EMB) was included in initial treatment [28,29].
All specimens showed full drug sensitivity. After termination of
therapy, individuals underwent X-ray re-examination and bacte-
riological sputum negativity was confirmed. In the case of LTBI,
chemoprophylaxis with INH was given for 9 months [30].
Controls were non-BCG-vaccinated individuals admitted to the
hospital for non-TB-related diseases.
Restimulation assay
The 7-day restimulation assay has been described previously
[31]. In brief, peripheral blood mononuclear cells (PBMC) were
isolated by density centrifugation (Biocoll, Biochrom) in accor-
dance with manufacturer’s instructions. PBMC (2610
5) were
cultured in 200 ml RPMI 1640 medium (GIBCO, Invitrogen)
containing 7.5% human serum (Sigma-Aldrich), 100 U/ml
penicillin, 100 mg/ml streptomycin, 1 mM L-glutamine and
10 mM HEPES (all PAA laboratories) in 96-well round-bottom
plates (NUNC). PBMC were stimulated with purified protein
derivative (PPD) from Mtb (10 mg/ml) (Statens Serum Institute),
recombinant Mtb fusion protein ESAT6-CFP10 (5 mg/ml)
(courtesy of T.H. Ottenhoff/Leiden University) [32], recombinant
EBNA1 protein from Epstein-Barr virus (EBV, 5 mg/ml),
recombinant p65 protein from human cytomegalo-virus (HCMV,
5 mg/ml) or recombinant chimeric Chagas multiantigen from
Trypanosoma cruzi (TcF, 5 mg/ml) (all Prospec). All stimuli were
added at the beginning of culture and cells were kept at 37uC and
5% CO2. Cells were re-stimulated on day 6 with the same
concentration of antigens, and Staphylococcal enterotoxin B from
Staphylococcus aureus (SEB - Sigma-Aldrich) was also included as
positive control for cytokine secretion (1 mg/ml). Brefeldin A
(10 mg/ml) (Sigma-Aldrich) was added 4 h later and cells were
cultured for an additional 12 h.
Intracellular cytokine staining (ICS)
After the 7-day stimulation period, cells were fixed and
permeabilized using BD cytofix/cytoperm
TM (BD Biosciences)
according to manufacturer’s instructions. Cells were then washed
twice in BD perm/wash
TM solution (BD Biosciences), and
incubated at 4uC for 45 min with fluorescence-conjugated
antibodies directed against surface and intracellular proteins.
The following antibodies were used: anti-CD4 APC-Cy7, anti-
CD8 PerCP-Cy5.5, anti-CD45RO PE-Cy7, anti-CD45RA PE-
Cy7, anti-CCR7 APC, anti-GranzymeB Alexa700, anti-HLA-DR
APC, anti-CD107a/b FITC, anti-CD40L APC, anti-CTLA-4
APC (all BD Biosciences); anti-IFNc Pacific Blue, anti-granulysin
PE, anti-perforin FITC (all eBioscience); anti-CCR5 Alexa647
(AbD Serotec); anti-CXCR3 FITC (BioLegend). After staining,
cells were washed twice in BD perm/wash
TM solution and
resuspended in PBS containing 5% FCS. Measurements were
Table 1. Characteristics of the study population.
Participants LTBI
LTBI after
therapy
Active TB
patients
TB patients
after therapy
NTM-infected
children/adolescents Healthy controls
Total number 9 16 7 9 5 13
Male 5 8 3 6 4 7
Female 4 8 4 3 1 6
Average range, years
(median)
2–17 (13) 1–15 (10) 1–16 (14) 1–16 (6) 2–13 (7) 1–15 (9)
Tablenotes: Latent TB infection LTBI; nontuberculous mycobacteria NTM; tuberculosis TB.
doi:10.1371/journal.pone.0029367.t001
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data was analyzed using FACS-Diva software 6.1 (both BD
Biosciences) and FlowJo version 8.8.4 (Treestar).
Proliferation assays
To measure the proliferation of T cells, PBMC were stained
using CellTrace
TM CFSE Cell Proliferation Kit (Invitrogen)
according to manufacturer’s instructions. Afterwards PBMC were
plated and stimulated as described above.
Generation of granulysin-expressing T cell lines
PBMC from adult TST
+ donors were obtained and several wells
were stimulated with PPD using the 7-day restimulation assay
described above. After stimulation, cells were pooled and stained
with CD3 APC, CD4 APC-Cy7, CD8 PerCp-Cy5.5, CD25 PE-
Cy7, CXCR3 FITC (all BD Bioscience). Cells showing a CD3
+,
CD4
+, CD8
2, CD25
+, CXCR3
+ phenotype were sorted using a
BD FACS ARIA 2 (Becton Dickinson). A limiting dilution of 0.3
and 0.5 cells per well in a 96-well plate (Nunc) was performed and
cells were cocultured with 1610
5 autologous irradiated PBMC (28
grays). PPD (10 mg/ml) and recombinant IL-2 (40 U/ml) (Active
Bioscience) were added in the first round of stimulation. Wells that
showed visible growth were further expanded with irradiated
PBMC, PHA (2.5 mg/ml) (Invitrogen) and IL-2 (40 U/ml).
Assessment of anti-mycobacterial activity of T cell lines
Autologous PBMC were isolated as described above. Monocytes
were then isolated using a Monocyte Isolation Kit II (Miltenyi) and
1610
4 monoyctes were plated per well in 96-well round-bottom
plate in RPMI 1640 medium containing 7.5% human serum,
1 mM L-glutamine and 10 mM HEPES. Monocytes were infected
with Mtb H37Rv at a multiplicity of infection (MOI) of 5 at 37uC
and 5% CO2 for 24 h. After washing, different T cell lines were
added at an effector:target ratio of 10:1. Plates were incubated for
an additional 24 h at 37uC and 5% CO2. Afterwards cells were
lysed with 100 ml of 0.1% Triton-X100 in PBS. Fifty ml of different
dilutions of lysed cell suspension (1:100; 1:1,000; 1:10,000;
1:100,000) were plated on 7H11 agar plates. Plates were incubated
at 37uC and colony forming units (CFU) were counted after 4
weeks.
Data analysis
Statistical analyses were performed using GraphPad Prism
V.5a software. For analysis of the CD4
+ CD45RO
+ T cell
compartment and granulysin expression, study groups were
compared using the Mann-Whitney U test. The same test was
used for the comparison of T cell lines lacking or expressing
granulysin. Changes in median fluorescence intensity of the
different immune markers, between granulysin-negative and
granulysin-expressing CD4
+ CD45RO
+ T cells, and in memory
phenotype of granulysin-expressing T cells, were compared using
the Wilcoxon signed-rank test.
Results
Antigen-specific induction of granulysin-expressing CD4
+
CD45RO
+ T cells
TB-experienced children and adolescents, before or after
treatment, presented higher frequency of CD4
+ CD45RO
+ T
cells after 7-day restimulation with Mtb antigens when compared
to controls (Figure 1A). The frequency of CD4
+ CD45RO
+ T cells
in individuals infected with NTM and in controls was not changed
after stimulation with the recombinant fusion protein ESAT6-
CFP10 (Figure 1B). These two proteins are absent from many
environmental mycobacteria as well as from BCG.. Proliferation
experiments revealed expansion of CD4
+ CD45RO
+ T cells after
stimulation with PPD or ESAT6-CFP10 (Figure 1C) and not with
control antigens (data not shown). This indicates enlargement of
the memory T cell pool rather than recruitment of naive T cells
during stimulation. On the contrary, CD8
+ CD45RO
+ memory
cells did not proliferate during 7-day restimulation and a
significant reduction in CD8
+ frequencies after antigen-specific
stimulation was observed (data not shown). Next, we investigated
the induction of CTL activation in the CD4
+ CD45RO
+ T cell
compartment by determining granulysin expression. The gating
strategy and expression of granulysin after antigen-specific
stimulation of CD4
+ T cells in a representative TB patient and
control sample are displayed in Figure 2A. Participants with TB –
regardless of drug therapy – were compared to those with NTM
infection and to controls (Figure 2B). A significant induction of
granulysin expression in antigen-specific memory T cells was
detected for both TB patients (p,0.001) and NTM-infected
individuals (p,0.01), but was absent in controls. Granulysin-
expressing T cells were reduced after stimulation with ESAT6-
CFP10 in Mtb-experienced individuals only (p,0.001). Stimula-
tion with Ag85, a protein shared by Mtb, BCG and NTM, did not
reveal significant differences between the three groups. Mtb-
unrelated antigens (TcF, HCMV, EBV) were also included for
further verification of antigen specificity. Stimulation with TcF did
not result in granulysin expression. In some TB patients as well as
in some controls, granulysin induction was observed after
stimulation with EBV and HCMV antigen, however, at low
frequency. Next, participants with Mtb infection were classified
according to clinical status and anti-TB therapy (Figure 2C). Both
individuals with active Mtb infection and LTBI showed a
significant increase in granulysin-expressing memory T cells after
PPD and ESAT6-CFP10 restimulation. A similar induction was
detected in participants that underwent TB drug therapy.
Since CD4
+CD45RO
+ memory T cells contributed to the vast
majority of granulysin-expressing cells after antigen restimulation
(Figure 2A), we interrogated whether granulysin
+ cells were
derived from proliferating antigen-specific CD45RO
+ memory T
cells (Figure S1). Stimulation with PPD and ESAT6-CFP10 caused
marked proliferation of CD45RO
+ memory T cells, which were
the main source of granulysin within the CD4
+ T cell
compartment. In contrast, the mitogen PHA induced strong T
cell proliferation but almost no granulysin induction.
Granulysin-expressing T cells reveal central and effector
memory phenotype, are long-lived and coexpress IFNc
Further analysis revealed that after restimulation with ESAT6-
CFP10, the majority of granulysin-expressing T cells presented an
effector memory phenotype (CD45RA
2 CCR7
2)( p ,0.01)
(Figure S2). The same trend was observed after PPD restimulation,
but results did not reach statistical significance. We next
determined the longevity of this memory response after comple-
tion of TB drug therapy. To address this, we analyzed frequencies
of antigen-induced granulysin- and IFNc-expressing CD4
+
CD45RO
+ T cells in children recruited at different time points
after TB drug therapy (Figure 3A). During the first 20 months after
completion of drug therapy, both IFNc and granulysin were
observed. Children, who had completed TB drug therapy more
than 20 months earlier, continued to show elevated frequencies of
granulysin-expressing CD4
+ CD45RO
+ T cells, which were
significantly higher compared to IFNc (p,0.01). Hence, granuly-
sin-expressing CD4
+ T cells specific for Mtb are long-lived. The
coexpression of granulysin and IFNc was analyzed more precisely
Cytolytic CD4
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IFNc-producing single-positive memory T cells remained stable
over time, whereas the proportion of IFNc and granulysin double-
positive memory T cells declined. However, the fraction of
granulysin single-positive memory T cells increased markedly over
time. These data suggest a shift over time from IFNc-/granulysin
double-positive memory T cells towards long-lived granulysin
single-positive T cells after completion of drug therapy.
Coexpression of surface markers and additional CTL
effector molecules by granulysin-expressing CD4
+ T cells
Memory T cells are characterized by the expression of distinct
sets of chemokine receptors. We analyzed expression of the
chemokine receptors, CCR5 and CXCR3, characteristic for type
1 helper T cells [33,34], as well as activation markers (HLA-DR,
CTLA-4, CD40L) [35,36,37] and additional cytotoxic markers
(granzyme B and perforin) in granulysin-expressing T cells upon
antigen stimulation (Figure 4). CXCR3 was significantly elevated
on granulysin
+ T cells, whereas CCR5 expression remained stable.
Antigen-specific CD4
+ CD45RO
+ T cells also surface-expressed
activation markers CD40L, CTLA-4 and HLA-DR at elevated
intensity. Moreover, the cytotoxic proteins granzyme-B and
perforin were highly induced in granulysin-expressing CD4
+ T
cells (Figure 4).
CD4
+ T cell lines reduce Mtb burden in infected target
cells in a granulysin-dependent fashion
Granulysin has been demonstrated to reduce Mtb burden in
infected target cells [22]. We therefore infected monocytes and
cocultured them with autologous granulysin high or low T cell
lines (Figure 5). Growth of Mtb was significantly decreased in
cultures with granulysin-high, compared to granulysin-low, T cell
lines reemphasizing their important role in the control of Mtb
replication.
Discussion
CTL play an essential role in the immune control of TB [18].
Principally, CTL use two major pathways for elimination of
infected target cells. Surface expression of FAS-L causes apoptosis
in target cells expressing FAS. Exocytosis of granular content into
the immunologic synapse, between CTL and target cells, causes
lysis [38]. Effector proteins contained within cytotoxic granules
include perforin, granzymes and granulysin [39]. Granulysin has
direct antimicrobial activity against a wide spectrum of bacteria,
parasites and fungi [22]. Notably, even though CTL activity is
typically associated with CD8
+ T cells, several reports have
demonstrated Mtb-associated CTL activity in CD4
+ T cells in TB
[21,40,41]. Here we analyzed granulysin-expressing CD4
+ T cells
in childhood/adolescent TB and harnessed this T cell set for
differential diagnosis of TB [31]. We detected profound induction
of memory T cells defined as CD4
+ CD45RO
+ T cells after
restimulation with Mtb antigens (Figure 1A,B). Restimulation
significantly increased the frequencies of CD4
+ CD45RO
+
memory T cells in all study groups with Mtb infection, with or
without TB drug therapy.
Study participants infected with NTM showed heightened
frequencies of memory T cells after restimulation with the
crossreactive PPD, but not after restimulation with Mtb-specific
ESAT6-CFP10. In controls, frequencies of memory T cells
remained unchanged after restimulation.
A possible reason for the marked induction of CD45RO
+ T cells
during 7-day culture could be the recruitment of naive cells to the
memory compartment. We consider this possibility unlikely
because CD45RO
+ memory T cells were not induced by the
Mtb-specific antigen ESAT-CFP10 in controls and in individuals
infected with NTM. To verify whether only T cells of the memory
compartment were induced by restimulation, we performed
proliferation assays, which provided compelling evidence that
memory T cells exclusively proliferated after restimulation with
PPD and ESAT6-CFP10 (Figure 1C). Induction of CD8
+
CD45RO
+ memory cells could not be detected and frequencies
of CD8+ T cells decreased significantly after stimulation (data not
shown). Granulysin expression by T cells plays a crucial role in
immune defence against TB [18,42]. Yet, the 7-day restimulation
assay is highly sophisticated and hence, in its present form, not
ready for point-of-care diagnosis of childhood/adolescent TB.
Granulysin induction in memory T cells of study participants
infected with Mtb, with or without TB drug therapy, was profound
(p,0.0001) after PPD or ESAT6-CFP10 restimulation as com-
pared to controls (Figure 2B). This elevated granulysin remained
high in individuals newly diagnosed with active TB (p,0.001) or
LTBI (p,0.01) as compared to controls (Figure 2C). Better
measures for diagnosis of childhood TB are urgently needed [11].
Our data favour a 7-day in vitro restimulation assay for TB
diagnosis in children. Flow cytometry has been exploited for TB
diagnosis by numerous groups [43,44,45]. Most studies focused on
intracellular IFNc and tumour necrosis factor-alpha (TNFa)
expression after restimulation, which increased sensitivity over
IGRA. Despite the fact that our study was performed in a low-
incidence high-income country, where the number of study
participants was limited, our findings, suggest the inclusion of
granulysin in flow cytometry-based assays as a diagnostic marker
for childhood TB. We did not detect any correlation between
antigen-specific granulysin expression of CD4+ CD45RO+
memory T cells and age distribution. Since age has been reported
as one of the most important risk factors in childhood/adolescent
TB, further studies comparing granulysin in different age groups
would be crucial [46].
Consistent with previous studies from our group, the 7-day in
vitro restimulation assay caused profound reactivation of
CD45RO
+ memory T cells [31]. These CD4
+ CD45RO
+ memory
T cells were the main source of granulysin as indicated by
exclusive expression in CD4
+ CD45RO
+ T cells undergoing cell
division (Figure S1).
Additional experiments revealed an equal contribution of
central and effector memory T cells after PPD re-stimulation
and a preponderance of effector memory CD4
+ T cells after
Figure 1. Increase of the CD4
+ CD45RO
+ memory T cell population after Mtb antigen stimulation. A. Representative density plot
showing gating strategy for CD4 and CD8 lymphocytes (left). CD4
+ T cells were further gated for CD45ROlow versus high expression after: no
stimulation (unstimulated), restimulation with purified protein derivative (PPD) or with ESAT6-CFP10. Representative examples for control (left) and
active tuberculosis (TB) (right) are shown. B. Percentage of CD4
+ CD45RO
+ memory T cells unstimulated (left), after PPD (right) or ESAT6-CFP10
(bottom left) restimulation of 9 latent TB infection (LTBI) before therapy (light grey bar), 12 LTBI after drug therapy (dark grey bar), 7 active TB before
drug therapy (light grey bar), 8 active TB after drug therapy (dark grey bar), 4 nontuberculous mycobacteria (NTM) (grey bar) and 13 controls without
mycobacterial infection (white bar). Median represented by horizontal line, interquartile range by box, and range by whiskers. Significant difference of
groups, in comparison to controls, is indicated (Mann-Whitney U test). C. Representative carboxyfluorescein diacetate succinimidyl ester (CFSE)
proliferation dot plot of CD4
+ T cells either unstimulated or after restimulation with PPD and ESAT6-CFP10, respectively.
doi:10.1371/journal.pone.0029367.g001
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+ CD45RO
+ granulysin
+ memory T cells after Mtb antigen stimulation. A. Representative pseudo-color plot
for CD45RO and granulysin expression by CD4
+ T cells from control (left) and active tuberculosis (TB) (right) after 7-day restimulation. Peripheral
blood mononuclear cells (PBMC) were unstimulated, stimulated with purified protein derivative (PPD), ESAT6-CFP10, or recombinant Trypanosoma
cruzi antigen (TcF). B. Granulysin expression depicted for each antigen as percentage of CD4
+ CD45RO
+ memory T cells. Frequencies of 38 TB-
experienced individuals (TB contacts) [latent TB infection (LTBI) and active TB before and after drug therapy] (circles), 5 nontuberculous mycobacteria
Cytolytic CD4
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by superior processing of the recombinant protein resulting in
faster activation and transition of resting central effector memory
T cells into an effector memory phenotype. These findings are
consistent with the data of others [47].
Di Liberto et al. [48] suggested that serum concentration of
granulysin in children could be exploited for monitoring outcome
of drug therapy in TB. In this study the serum concentration of
granulysin before and after drug therapy differed. This effect was
not seen at the T cell level in our study (Figure 2). On the contrary,
our data revealed a constant high frequency of granulysin
+
memory T cells even 20 months after termination of drug therapy
(Figure 3A). Our data emphasize that granulysin is expressed by
long-lived memory T cells. Hence its potential as immunologic
marker for long-lived memory T cells in TB, should be exploited.
In support of this notion, a recent report has shown that CD4
+ and
CD8
+ T cells of BCG-vaccinated infants express granulysin after ex
vivo stimulation with either BCG or PPD [49]. Moreover,
vaccination with recombinant M. smegmatis, coexpressing granuly-
sin and IL-12, reduced pulmonary CFU in lungs of Mtb-
challenged mice [50].
A proportion of the memory T cell pool coexpressed IFNc and
granulysin (Figure 3B). Coexpression of these two key molecules in
immune defense against Mtb has previously been shown for T cell
clones [41,51]. Our study identifies, for the first time, this T cell
subset in children/adolescents after TB drug therapy and a shift
from granulysin/IFNc double-positive CD4
+ T cells towards
single-granulysin
+ memory CD4
+ T cells, over time (Figure 3B).
The phenotype of human CD4
+ CTL has not been investigated
in detail. Thus, we characterized additional surface markers and
other cytotoxic proteins in granulysin
+ CD4
+ T cells (Figure 4).
Amongst chemokine receptors characteristic for type 1 helper T
cells, CXCR3 was significantly upregulated on granulysin
+ T cells,
whereas CCR5 expression remained unchanged. Bastian et al.
[47], found elevated expression of CXCR3 as well as CCR5 on
the surface of CD4
+ CTL after stimulation with crude Mtb cell
wall extracts. Increased expression of activation markers, including
CD40L, CTLA-4 and HLA-DR, indicates that granulysin-
(NTM) (squares), 12 controls without mycoabacterial infection (diamonds) are shown. PPD, ESAT6-CFP10, Ag85A/B, TcF, recombinant human
cytomegalo-virus (HCMV) antigen Pp65, and recombinant Epstein-Barr virus (EBV) antigen EBNA-1, were used as antigens. C. Percentage of
granulysin-expressing CD4
+ CD45RO
+ memory T cells from TB-experienced individuals: 10 LTBI before therapy (light grey bar), 12 LTBI after drug
therapy (dark grey bar), 5 active TB (light grey bar), 9 active TB after drug therapy (dark grey bar) and 12 controls (white bar). Individual background
values of unstimulated controls were subtracted. Median represented by horizontal line, interquartile range by box, and range by whiskers.
Significant difference of groups, in comparison to controls, is indicated (Mann-Whitney U test).
doi:10.1371/journal.pone.0029367.g002
Figure 3. Antigen-specific induction of granulysin and/or IFNc in CD45RO
+ memory T cells of TB patients at different time points
after drug therapy. A. Expression of granulysin (white circles) and interferon-gamma (IFNc) (black squares) of CD4
+ CD45RO
+ memory T cells in
peripheral blood mononuclear cells (PBMC) stimulated with purified protein derivative (PPD) (left) or recombinant ESAT6-CFP10 (right). Individual
background values of unstimulated controls were subtracted. Medians for each group and statistical significance are indicated (Wilcoxon signed-rank
test). B. Percentage of CD4
+ CD45RO
+ memory T cells expressing granulysin alone [granulysin single-positive (sp); white bars], IFNc alone (IFNc sp;
grey bars) or both [granulysin/IFNc double-positive (dp); light grey bars] after stimulation with PPD (left) or recombinant ESAT6-CFP10 (right). Median
represented by horizontal line, interquartile range by box, and range by whiskers. Significance between different groups indicated (Mann-Whitney U
test).
doi:10.1371/journal.pone.0029367.g003
Cytolytic CD4
+ T Cells as Candidate Markers in TB
PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e29367producing CD4
+ T cells are highly activated (Figure 4). Expression
of the costimulatory surface molecule CD40L on CD4
+ CTL has
not been described before. Expression of CTLA-4 on Mtb-specific
CD4
+ T cell clones has been found to inhibit lytic activity after
crosslinking [52]. Thus, CTLA-4 is likely involved in the
regulation of CD4
+ CTL.
Our experiments focused on granulysin expression by CD4
+
CTL. Two other major cytolytic proteins in the lytic granule,
perforin and granzyme B, were found to be coexpressed with
granulysin (Figure 4) [22,39]. This confirms previous observations
showing that CD4
+ T cells upregulate perforin and granzyme B
after in vitro restimulation with Mtb [21]. This induction of
Figure 4. Median fluorescence intensity of different immune markers in granulysin-expressing CD4
+ CD45RO
+ memory T cells.
PBMC (2610
5) from active TB and LTBI were stimulated with purified protein derivative (PPD), recombinant ESAT6-CFP10 or left unstimulated
(unstim). Median fluorescence intensity (MFI) was measured in CD4
+ CD45RO
+ memory T cells and compared to T cells expressing granulysin upon
restimulation (black bar) versus granulysin-negative T cells (white bar). Background expression is shown for unstimulated controls. Different numbers
of patient samples were included in the analysis (CCR5 n=9; CXCR3 n=10; CD40L n=7; CTLA-4 n=15; HLA-DR n=8; granzyme-B n=21; perforin
n=12). Bars indicate arithmetic mean and overlying error bars represent standard error. Significant differences between granulysin
+ and granulysin
2
T cells are indicated (Wilcoxon signed-rank test).
doi:10.1371/journal.pone.0029367.g004
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granulysin-expressing memory CD4
+ T cells in TB. This notion
could be further strengthened by the co-culture experiments with
granulysin-expressing CD4
+ T cell lines (Figure 5). As discussed
above, the second pathway for target cell killing by CTL is
mediated by CD95/CD95L interactions [53]. This route of
induced apoptotic cell death can be excluded in our assay since
CD95L on the cell surface of granulysin
+ T cells was not detected
(data not shown). Consistent with previous studies we assume that
CD4
+ CTL primarily use the cytotoxic granule mechanism rather
than the CD95-dependent pathway for target cell killing
[54,55,56].
In conclusion, we describe antigen-specific expression of
granulysin by long-lived central and effector memory CD4
+ T
cells in Mtb-infected children and adolescents. Hence, we suggest
further exploring the potential of this immune marker for
diagnosis of childhood/adolescent TB.
Supporting Information
Figure S1 Induction of granulysin exclusively in prolif-
erating antigen-specific CD45RO
+ memory T cells.
Representative dot plots (top) and histograms (bottom) of
frequencies of carboxyfluorescein diacetate succinimidyl ester
(CFSE)high and CFSElow populations and percentages of CD4
+
CD45RO
+ T cells expressing granulysin in active tuberculosis (TB)
after restimulation with purified protein derivative (PPD) or
ESAT6-CFP10. As positive control (far right) cells were incubated
with 5 mg/ml phytohemagglutinin (PHA). Results showing are
representative for six independent experiments.
(TIF)
Figure S2 Memory phenotype of granulysin-expressing
CD4
+ T cells in children/adolescents. Peripheral blood
mononuclear cells (PBMC) of active tuberculosis (TB) and latent
TB infection (LTBI) were restimulated with purified protein
derivative (PPD) (left) or ESAT6-CFP10 (right). Cells were stained
for granulysin, CD45RA and CCR7 and granulysin
+ cells grouped
based on distribution of surface markers. Means for each group
and significant differences between central memory T cells (Tcm)
and effector memory T cells (Tem) are indicated (Wilcoxon signed-
rank test).
(TIF)
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